Blog

Rahul Gosain: US FDA approval of Durvalumab for resectable NSCLC with Mara Antonoff and Sandip Patel

oncbrothers.com

Oct 21, 2024, 13:21

Rahul Gosain: US FDA approval of Durvalumab for resectable NSCLC with Mara Antonoff and Sandip Patel

”Lung Cancer: We speak about the US FDA approval of Durvalumab based off AEGEAN (and options in perioperative/postoperative) for resectable Non-Small Cell Lung Cancer with Mara Antonoff and Sandip Patel.

Full Discussion:

Link 1.
Link 2.
Also on ‘Oncology Brothers’ podcast.”

View attached video.

Drs. Rohit Gosain and Rahul Gosain (aka Oncology Brothers), are medical oncologists/hematologists. Through their social media platforms like X/Twitter, they actively engage with their audience. With their own YouTube channel and podcast, they provide accessible resources for cancer patients and their families. Additionally, their participation in live conferences ensures that cancer patients receive the best care closer to home, reflecting their commitment to advancing oncology and improving patient outcomes through education and outreach.

AEGEAN cancer Durvalumab Lung cancer Mara Antonoff non small cell lung cancer OncoDaily Oncology Rahul Gosain Sandip Patel US FDA Oncology Drugs Advisory Committee

Mark Ruffalo and Brain Cancer: How He Went Against, How He Survived, and More

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

FDA approves Methotrexate for Pediatric acute Lymphoblastic Leukemia

Special Coverage